NCT06410872

Brief Summary

Since there is conflicting and insufficient data regarding CH personality and addictive behaviour, the investigators will investigate risk- and reward seeking behaviour in people with cluster headache. If an increased tendency towards this behaviour is shown, it will add to the clinical knowledge of cluster headache and possible lead to insights in a common biological susceptibility.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 23, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 8, 2019

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
2.4 years until next milestone

First Posted

Study publicly available on registry

May 13, 2024

Completed
Last Updated

May 13, 2024

Status Verified

May 1, 2024

Enrollment Period

2.7 years

First QC Date

October 8, 2019

Last Update Submit

May 8, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Difference in mean total score on the Zuckerman Sensation Seeking Scale between groups

    Between group difference

    One time-point

  • Difference in mean total number of pumps during second trial between groups

    Between group difference

    One time-point

Secondary Outcomes (2)

  • Difference in mean scores on the array of psychometric tests between groups

    One time-point

  • Difference in mean scores on the BART between groups and between the first and second BART within groups

    One time-point

Study Arms (4)

Episodic cluster headache

Patients diagnosed according to ICHD3 criteria with episodic cluster headache

Diagnostic Test: BART Task

Chronic cluster headache

Patients diagnosed according to ICHD3 criteria with chroniccluster headache

Diagnostic Test: BART Task

Migraine

Patients diagnosed according to ICHD3 criteria with migraine (MA and MO)

Diagnostic Test: BART Task

Healthy controls

Healthy controls, sex- and age-matched without current diagnosis of headache disorder

Diagnostic Test: BART Task

Interventions

BART TaskDIAGNOSTIC_TEST

The Zuckerman's Sensation Seeking Scale version-V (SSS-V) - Four-factor score, The Barret Impulsiveness Scale (BIS), Gormally's Binge Eating Scale (BES), The World Health Organization-developed AUDIT (Alcohol Use Disorders Identification Test) screen, The CAGE questionnaire for substance abuse-adapted to include drugs, Gamblers Anonymous's 20 Questions (GA20), Hospital Anxiety and Depression Scale (HADS)

Also known as: Questionnaires
Chronic cluster headacheEpisodic cluster headacheHealthy controlsMigraine

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People with episodic (n=35) and chronic cluster headache (n=35) will be recruited from the Neurology outpatient clinic of Leiden University Medical Centre. Migraineurs (n=35) will be recruited from the LUMINA pool from people with migraine who have previously expressed interest in being contacted for future studies. Healthy controls (n=35) will be recruited from a pool of prior research-study participants, who have previously expressed interest in being contacted for future studies. We aim to achieve a 3:1 male:female ratio.

You may qualify if:

  • Age 18-64 years
  • Normal or corrected vision with acuity up to 20/60
  • Presence of episodic (n=35) or chronic (n=35) cluster headache or migraine with or without arua (n=35), diagnosed according to the International Classification of Headache Disorders criteria, 3rd edition (ICHD-3, 3.1.1)

You may not qualify if:

  • Diagnosis of uncorrected visual problems (myopia/presbiopia, peripheral vision problems or legal blindness)
  • Current diagnosis of generalized anxiety disorder, depression or other psychiatric illness
  • Other acute, unstable medical conditions or serious chronic diagnoses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

LUMC

Leiden, South Holland, Netherlands

Location

MeSH Terms

Conditions

Cluster Headache

Condition Hierarchy (Ancestors)

Trigeminal Autonomic CephalalgiasHeadache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Rolf Fronczek, MD / PhD

    Neurologist LUMC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

October 8, 2019

First Posted

May 13, 2024

Study Start

April 23, 2019

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

May 13, 2024

Record last verified: 2024-05

Locations